WHO: Key-changes to the treatment of drug-resistant tuberculosis + Civil society information session, Thu 19 Dec

Published on December 12, 2019

WHO announces changes to the treatment of drug-resistant tuberculosis

Significant improvements in treatment outcomes and quality of life for patients with drug-resistant tuberculosis (TB) are expected, following key updates to treatment approaches, announced by the World Health Organization (WHO) in a Rapid Communication released today. The changes suggested by the evidence review are the phasing out of shorter injectable containing regimens and the introduction of a shorter all-oral bedaquiline containing regimen for eligible MDR/RR-TB patients. In addition, in patients with extensively drug resistant (XDR -TB) (2), a shorter regimen with bedaquiline, pretomanid and linezolid may be used under operational research conditions as an alternative to the longer regimen. This Rapid Communication has been released in advance of the updated guidelines expected in 2020, to inform national TB programmes and other stakeholders about the key implications for treatment of MDR/RR-TB and XDR-TB in order to allow for rapid transition and planning at the country level.

Read more HERE

 

The World Health Organization is organizing an Information Session for civil society representatives to provide an update on the WHO TB guideline development process.

The Session will be held on Thursday 19 December 14:00-15:00 CEST. Please register by Tuesday 17 December to attend the Information Session.

Click here to register WebEx connection details will be provided to registered participants. Q&A discussions will be enabled over chat.

For more information please contact Anna Stukalova: [email protected]

Other news

Webinar1: Surviving TB: what can we learn and do better?

December 6, 2019
Join us on Wednesday 11 December for our first Webinar - Join us HEREAnd do check out our new People Knowledge page with videos, stories and voices from people in our TB community!

Indian Express: Country must unite in the effort to eradicate tuberculosis by 2025

January 4, 2020
Written by Dr Harsh Vardhan | Updated: January 4, 2020 12:57:45 pmAt the End TB Summit, 2018, the prime minister of India made a bold commitment to end tuberculosis by 2025 — five years ahead of the global target. To many, this goal may seem unattainable, but as someone who has worked at the grass roots all his life and had the privilege to dream of a polio-free India — and work for it for almost